|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4328245A
(en)
|
1981-02-13 |
1982-05-04 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
|
US4410545A
(en)
|
1981-02-13 |
1983-10-18 |
Syntex (U.S.A.) Inc. |
Carbonate diester solutions of PGE-type compounds
|
|
US4409239A
(en)
|
1982-01-21 |
1983-10-11 |
Syntex (U.S.A.) Inc. |
Propylene glycol diester solutions of PGE-type compounds
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
CS233665B1
(en)
|
1983-01-06 |
1985-03-14 |
Antonin Holy |
Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
US6448392B1
(en)
|
1985-03-06 |
2002-09-10 |
Chimerix, Inc. |
Lipid derivatives of antiviral nucleosides: liposomal incorporation and method of use
|
|
CS263951B1
(en)
|
1985-04-25 |
1989-05-12 |
Antonin Holy |
9-(phosponylmethoxyalkyl)adenines and method of their preparation
|
|
CS263952B1
(en)
|
1985-04-25 |
1989-05-12 |
Holy Antonin |
Remedy with antiviral effect
|
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
|
CS263955B1
(cs)
|
1986-07-18 |
1989-05-12 |
Holy Antonin |
Způsob výroby N-(3-hydroxy-2-fosfonylmethoxypropyl)derivátů heterocyklických bází
|
|
CS263953B1
(cs)
|
1986-07-18 |
1989-05-12 |
Holy Antonin |
Způsob výroby 9-(S)- nebo 9-(RS)-(3 hydroxy-2-íosfonylmethoxypropyl)- ads-ninu
|
|
CS264222B1
(en)
|
1986-07-18 |
1989-06-13 |
Holy Antonin |
N-phosphonylmethoxyalkylderivatives of bases of pytimidine and purine and method of use them
|
|
CS263956B1
(cs)
|
1986-07-18 |
1989-05-12 |
Holy Antonin |
Způsob výroby 9- (S) -, (3-hydroxy-2-fosfonylmetboxypropyl) adeninu
|
|
DE3778626D1
(de)
|
1986-09-27 |
1992-06-04 |
Toyo Jozo Kk |
Nukleosid-phospholipid-konjugat.
|
|
US5650510A
(en)
*
|
1986-11-18 |
1997-07-22 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiviral phosphonomethoxyalkylene purine and pyrimidine derivatives
|
|
IL84477A
(en)
*
|
1986-11-18 |
1995-12-08 |
Bristol Myers Squibb Co |
History of Phosphonomethoxyalkylene Purinopyrimidine and Pharmaceutical Preparations Containing Them
|
|
GB8724252D0
(en)
|
1987-10-15 |
1987-11-18 |
Ici Plc |
Fungicides
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
US6599887B2
(en)
|
1988-07-07 |
2003-07-29 |
Chimerix, Inc. |
Methods of treating viral infections using antiviral liponucleotides
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
US5033352A
(en)
|
1989-01-19 |
1991-07-23 |
Yamaha Corporation |
Electronic musical instrument with frequency modulation
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
US5688778A
(en)
|
1989-05-15 |
1997-11-18 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Nucleoside analogs
|
|
US5411947A
(en)
|
1989-06-28 |
1995-05-02 |
Vestar, Inc. |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
CZ285420B6
(cs)
|
1990-04-24 |
1999-08-11 |
Ústav Organické Chemie A Biochemie Avčr |
N-(3-Fluor-2-fosfonylmethoxypropyl)deriváty purinových a pyrimidinových heterocyklických bazí, způsoby jejich přípravy a použití
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
EP0533825B1
(en)
|
1990-06-15 |
1996-04-24 |
Wake Forest University |
Ether lipid-nucleoside covalent conjugates
|
|
DE4026265A1
(de)
|
1990-08-20 |
1992-02-27 |
Boehringer Mannheim Gmbh |
Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
|
|
EP0481214B1
(en)
|
1990-09-14 |
1998-06-24 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Prodrugs of phosphonates
|
|
JP3257675B2
(ja)
|
1990-10-12 |
2002-02-18 |
マックス−プランク−ゲゼルシャフト ツール フェルデルング デル ビッセンシャフテン エー．ファウ． |
修飾リボザイム
|
|
ATE141502T1
(de)
|
1991-01-15 |
1996-09-15 |
Alcon Lab Inc |
Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen
|
|
US5212162A
(en)
|
1991-03-27 |
1993-05-18 |
Alcon Laboratories, Inc. |
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
|
|
GB9126209D0
(en)
|
1991-12-10 |
1992-02-12 |
Orion Yhtymae Oy |
Drug formulations for parenteral use
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5652094A
(en)
|
1992-01-31 |
1997-07-29 |
University Of Montreal |
Nucleozymes
|
|
GB9205917D0
(en)
|
1992-03-18 |
1992-04-29 |
Smithkline Beecham Plc |
Pharmaceuticals
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
US5532225A
(en)
|
1992-07-31 |
1996-07-02 |
Sri International |
Acyclic purine phosphonate nucleotide analogs as antiviral agents, and related synthetic methods
|
|
US6057305A
(en)
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
|
US6005107A
(en)
|
1992-12-23 |
1999-12-21 |
Biochem Pharma, Inc. |
Antiviral compounds
|
|
US6444656B1
(en)
|
1992-12-23 |
2002-09-03 |
Biochem Pharma, Inc. |
Antiviral phosphonate nucleotides
|
|
GB9226879D0
(en)
|
1992-12-23 |
1993-02-17 |
Iaf Biochem Int |
Anti-viral compounds
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
US5817647A
(en)
|
1993-04-01 |
1998-10-06 |
Merrell Pharmaceuticals Inc. |
Unsaturated acetylene phosphonate derivatives of purines
|
|
ATE199906T1
(de)
|
1993-06-29 |
2001-04-15 |
Mitsubishi Chem Corp |
Phosphonat-nukleotid ester-derivate
|
|
EP0719274A1
(en)
|
1993-09-17 |
1996-07-03 |
Gilead Sciences, Inc. |
Method for dosing therapeutic compounds
|
|
US5656745A
(en)
|
1993-09-17 |
1997-08-12 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
US5798340A
(en)
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
DE4418690A1
(de)
|
1994-05-28 |
1996-01-11 |
Boehringer Mannheim Gmbh |
Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel
|
|
DE59506763D1
(de)
|
1994-06-29 |
1999-10-14 |
Ciba Sc Holding Ag |
Neue Kristallmodifikation eines Diketopyrrolopyrrolpigments
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
|
US5696277A
(en)
|
1994-11-15 |
1997-12-09 |
Karl Y. Hostetler |
Antiviral prodrugs
|
|
US5977061A
(en)
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
|
US7517858B1
(en)
|
1995-06-07 |
2009-04-14 |
The Regents Of The University Of California |
Prodrugs of pharmaceuticals with improved bioavailability
|
|
CA2224710A1
(en)
|
1995-06-15 |
1997-01-03 |
Naoko Inoue |
Phosphonate nucleotide derivatives
|
|
US5717095A
(en)
|
1995-12-29 |
1998-02-10 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
|
CA2195262C
(en)
|
1996-01-18 |
2005-08-09 |
Masaru Ubasawa |
Phosphonate nucleotide compounds
|
|
US5877166A
(en)
|
1996-04-29 |
1999-03-02 |
Sri International |
Enantiomerically pure 2-aminopurine phosphonate nucleotide analogs as antiviral agents
|
|
US6686462B2
(en)
|
1997-02-28 |
2004-02-03 |
The Regents Of The University Of California |
Antiviral compounds and methods of administration
|
|
EP0994715A4
(en)
|
1997-03-24 |
2001-08-08 |
Lilly Co Eli |
DIFLUORONUCLEOSIDE-PHOSPHONIC ACIDS AND DERIVATIVES THEREOF
|
|
CA2315262C
(en)
|
1997-12-17 |
2009-11-10 |
Biocryst Pharmaceuticals, Inc. |
Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
|
|
US6350458B1
(en)
|
1998-02-10 |
2002-02-26 |
Generex Pharmaceuticals Incorporated |
Mixed micellar drug deliver system and method of preparation
|
|
US6455571B1
(en)
|
1998-04-23 |
2002-09-24 |
Abbott Laboratories |
Inhibitors of neuraminidases
|
|
AU4125099A
(en)
|
1998-06-01 |
1999-12-20 |
S & T Science And Technology Inc. |
Antiviral phosphorus derivatives of 4'-thio-5-ethyl-2'-deoxyuridine
|
|
AU2645199A
(en)
|
1998-11-18 |
2000-06-05 |
Viktor Veniaminovich Tets |
Dialkyl-1-aryl-1-(2,4-dioxo-5-amino-1,3-pyrimidin-5-yl)methy lphosphonates
|
|
US7026469B2
(en)
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
|
DE60038038T2
(de)
|
1999-12-03 |
2009-02-12 |
The Regents of The University of California at San Diego, La Jolla |
Phosphonatverbindungen
|
|
WO2001064693A1
(fr)
|
2000-02-29 |
2001-09-07 |
Mitsubishi Pharma Corporation |
Compose de nucleotide de phosphonate
|
|
CZ304734B6
(cs)
|
2000-07-21 |
2014-09-10 |
Gilead Sciences, Inc. |
Způsob přípravy 9-[2-(fosfonomethoxy)propyl]adeninu a 9-[2-(fosfonomethoxy)ethyl]adeninu
|
|
MY141789A
(en)
|
2001-01-19 |
2010-06-30 |
Lg Chem Investment Ltd |
Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
|
|
CZ292199B6
(cs)
|
2001-03-08 |
2003-08-13 |
Ústav organické chemie a biochemie AV ČR |
O-Fosfonomethylcholin a jeho alkylestery, způsob jejich přípravy a použití
|
|
RU2187509C1
(ru)
|
2001-03-26 |
2002-08-20 |
Закрытое акционерное общество "Производственно-коммерческая Ассоциация АЗТ" |
Производные 5'-h-фосфоната 3'-азидо-3'-дезокситимидина и фармацевтические композиции на их основе
|
|
KR20020097384A
(ko)
|
2001-06-20 |
2002-12-31 |
미쯔비시 도꾜 세이야꾸 가부시끼가이샤 |
기존의 약제에 내성변이를 가지는 바이러스에 유효한 약제
|
|
WO2003002580A1
(en)
|
2001-06-29 |
2003-01-09 |
Institute Of Organic Chemistry And Biochemistry Ofthe Academy Of Sciences Of The Czech Republic |
6-`2-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity
|
|
US20040023928A1
(en)
|
2001-10-31 |
2004-02-05 |
Colacino Joseph Matthew |
Phosphonate nucleotide and thiadiazole compounds for the treatment of smallpox
|
|
AU2002343556A1
(en)
|
2001-12-07 |
2003-06-23 |
Eli Lilly And Company |
Use of phosphonate nucleotide analogue for treating hepatitis b virus infections
|
|
AU2003231765B9
(en)
|
2002-04-26 |
2010-01-28 |
Gilead Sciences, Inc. |
Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
|
|
US7247621B2
(en)
|
2002-04-30 |
2007-07-24 |
Valeant Research & Development |
Antiviral phosphonate compounds and methods therefor
|
|
AU2003242428A1
(en)
|
2002-05-24 |
2003-12-12 |
Mitsubishi Pharma Corporation |
Drugs improved in tissue selectivity
|
|
WO2004096235A2
(en)
|
2003-04-25 |
2004-11-11 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
US7452901B2
(en)
|
2003-04-25 |
2008-11-18 |
Gilead Sciences, Inc. |
Anti-cancer phosphonate analogs
|
|
EP2359833A1
(en)
|
2003-04-25 |
2011-08-24 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
|
DE602004031115D1
(de)
|
2003-06-16 |
2011-03-03 |
Acad Of Science Czech Republic |
Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
|
|
US7553825B2
(en)
|
2003-12-30 |
2009-06-30 |
Gilead Sciences, Inc. |
Anti-proliferative compounds, compositions, and methods of use thereof
|
|
WO2005090370A1
(en)
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
|
AU2005216298B2
(en)
|
2004-02-26 |
2010-09-02 |
Baylor Research Institute |
Compositions and methods for the systemic treatment of arthritis
|
|
WO2005087788A2
(en)
|
2004-03-04 |
2005-09-22 |
The Regents Of The University Of California |
Methods for preparation of nucleoside phosphonate esters
|
|
WO2006076015A2
(en)
|
2004-04-30 |
2006-07-20 |
The Regents Of The University Of California |
1-[2-(phosphonomethoxy)ethyl]-cytosine and analogs thereof
|
|
WO2006066074A2
(en)
|
2004-12-16 |
2006-06-22 |
The Regents Of The University Of California |
Lung-targeted drugs
|
|
CA2533721C
(en)
|
2005-01-25 |
2014-09-23 |
Dirtt Environmental Solutions Ltd. |
Method for wrapping a non-porous substrate object with a wood veneer
|
|
JP2008538354A
(ja)
|
2005-04-08 |
2008-10-23 |
キメリクス，インコーポレイテッド |
ウイルス感染症およびその他の内科疾患を治療するための化合物、組成物および方法
|
|
WO2006114064A2
(en)
|
2005-04-25 |
2006-11-02 |
Institute Of Organic Chemistry And Biochemistry Ofthe Academy Of Sciences Of The Czech Republic |
Use of compounds to enhance processivity of telomerase
|
|
WO2007002808A1
(en)
|
2005-06-29 |
2007-01-04 |
Gilead Sciences, Inc. |
Anti-nonmelanoma carcinoma compounds, compositions, and methods of use thereof
|
|
WO2007002912A2
(en)
|
2005-06-29 |
2007-01-04 |
Gilead Sciences, Inc. |
Anti-proliferative compounds, compositions, and methods of use thereof
|
|
US7449612B2
(en)
|
2006-04-11 |
2008-11-11 |
Catalytic Distillation Technologies |
Paraffin alkylation process
|
|
ES2600792T3
(es)
|
2006-05-03 |
2017-02-10 |
Chimerix, Inc. |
Alcoxialquilésteres metabólicamente estables de fosfonatos, fosfonatos nucleosídicos y fosfatos nucleosídicos antivirales o antiproliferativos
|
|
CN101089004A
(zh)
|
2006-06-13 |
2007-12-19 |
上海舒盟化学科技有限公司 |
一种新型的膦酸酯－核苷酸化合物
|
|
US20080268022A1
(en)
|
2007-02-23 |
2008-10-30 |
Mccabe R Tyler |
Mehtods for treating and preventing ailments caused by human papillomavirus
|
|
EP2144921A2
(en)
|
2007-02-27 |
2010-01-20 |
K.U. Leuven Research and Development |
Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
|
|
WO2008133966A1
(en)
|
2007-04-27 |
2008-11-06 |
Chimerix, Inc. |
Methods of reducing nephrotoxicity in subjects administered with nucleoside
|
|
EP2254582B1
(en)
|
2008-01-25 |
2016-01-20 |
Chimerix, Inc. |
Methods of treating viral infections
|
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
|
US20110060123A1
(en)
|
2008-04-30 |
2011-03-10 |
Kazunori Kataoka |
Charge conversional ternary polyplex
|
|
JP2012517443A
(ja)
|
2009-02-06 |
2012-08-02 |
アールエフエス ファーマ，エルエルシー |
癌及びウイルス感染の治療のためのプリンヌクレオシド一リン酸プロドラッグ
|
|
DE102009020261A1
(de)
|
2009-05-07 |
2010-11-11 |
Universität Hamburg |
Verfahren zur festphasengestützten Herstellung phosphatverbrückter Nucleosid-Konjugate
|
|
WO2010135520A1
(en)
|
2009-05-20 |
2010-11-25 |
Chimerix, Inc. |
Compounds, compositions and methods for treating viral infection
|
|
US8614200B2
(en)
|
2009-07-21 |
2013-12-24 |
Chimerix, Inc. |
Compounds, compositions and methods for treating ocular conditions
|
|
WO2011011710A1
(en)
|
2009-07-24 |
2011-01-27 |
Chimerix, Inc. |
Methods of treating viral infections
|
|
WO2011017253A1
(en)
|
2009-08-03 |
2011-02-10 |
Chimerix, Inc. |
Composition and methods of treating viral infections and viral induced tumors
|
|
WO2011053812A1
(en)
|
2009-10-30 |
2011-05-05 |
Chimerix, Inc. |
Methods of treating viral associated diseases
|
|
US9006218B2
(en)
|
2010-02-12 |
2015-04-14 |
Chimerix Inc. |
Nucleoside phosphonate salts
|
|
US20110218241A1
(en)
|
2010-03-06 |
2011-09-08 |
Cacao Bio-Technologies, Llc |
Antiviral epicatechins, epicatechin oligomers, or thiolated epicatechins from theobroma cacao for treatment of genital warts
|
|
PT2609923T
(pt)
|
2010-03-31 |
2017-08-30 |
Gilead Pharmasset Llc |
Processo para a cristalização de 2-(((s)- (perfluorofenoxi)(fenoxi)fosforil)amino)propanoato de (s)-isopropilo
|
|
EP2558466A4
(en)
|
2010-04-14 |
2013-11-13 |
Univ California |
PHOSPHONATES WITH REDUCED TOXICITY FOR THE TREATMENT OF VIRUS INFECTIONS
|
|
ES2604137T3
(es)
|
2010-08-31 |
2017-03-03 |
Chimerix, Inc. |
Derivados de éster de fosfonato y métodos de síntesis de los mismos
|
|
US9095599B2
(en)
|
2011-01-03 |
2015-08-04 |
Nanjing Molecular Research, Inc. |
O-(substituted benzyl) phosphoramidate compounds and therapeutic use
|
|
US9156874B2
(en)
|
2011-01-03 |
2015-10-13 |
Nanjing Molecular Research, Inc. |
Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs
|
|
HRP20161696T4
(hr)
|
2011-08-16 |
2023-10-13 |
Gilead Sciences, Inc. |
Tenofovir alafenamid hemifumarat
|
|
AU2012348332B2
(en)
*
|
2011-12-08 |
2017-06-29 |
Haifeng Chen |
Vectors harboring toxic genes, methods and uses therefor
|
|
CN102532199B
(zh)
|
2012-02-29 |
2015-08-05 |
刘沛 |
核苷类化合物之新型苄基胺基磷酸酯前药的结构与合成
|
|
EA201892769A3
(ru)
*
|
2013-03-15 |
2019-08-30 |
Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния |
Сложные диэфиры ациклических нуклеозидфосфонатов
|
|
CN103435672A
(zh)
|
2013-04-25 |
2013-12-11 |
刘沛 |
含有取代苄基的新型核苷磷酸酯前药的结构与合成
|
|
DK2999476T3
(en)
|
2013-11-15 |
2018-09-03 |
Chimerix Inc |
MORPHIC FORMS OF HEXADECYLOXYPROPYL PHOSPHONATE TESTERS
|
|
BR112017005111B1
(pt)
|
2014-09-15 |
2023-02-14 |
The Regents Of The University Of California |
Compostos análogos de nucleotídeo acíclico, composição farmacêutica contendo tais compostos, e usos da composição no tratamento de uma infecção por papilomavírus
|
|
CN106188192B
(zh)
|
2015-04-29 |
2019-09-10 |
刘沛 |
含d-氨基酸酯的核苷氨基磷酸/膦酸酯衍生物及其医药用途
|
|
CN106188139B
(zh)
|
2015-05-29 |
2020-02-18 |
江苏天士力帝益药业有限公司 |
替诺福韦单苄酯磷酸酰胺前药、其制备方法及应用
|
|
GB201509431D0
(en)
|
2015-06-01 |
2015-07-15 |
Equigerminal Sa |
Antiviral composition
|
|
WO2017048956A1
(en)
|
2015-09-15 |
2017-03-23 |
The Regents Of The University Of California |
Nucleotide analogs
|
|
CN107286190A
(zh)
|
2016-04-13 |
2017-10-24 |
刘沛 |
核苷之烃氧基苄基氨基磷酸/膦酸酯衍生物的制备及其医药用途
|
|
CN108602842B
(zh)
|
2016-11-02 |
2020-10-09 |
四川科伦博泰生物医药股份有限公司 |
杂环化合物及其制备方法和用途
|
|
CN108276444A
(zh)
|
2017-01-06 |
2018-07-13 |
米文君 |
一类新的化合物及其用途
|
|
SI4204421T1
(sl)
|
2020-08-27 |
2024-07-31 |
Gilead Sciences, Inc., |
Spojine in postopki za zdravljenje virusnih okužb
|
|
IL318465A
(en)
|
2022-07-21 |
2025-03-01 |
Antiva Biosciences Inc |
Compositions and dosage forms for the treatment of HPV infection and HPV-induced neoplasia
|